How to Read Mass Spectrometry Data on a Peptide COA: The Identity Verification Pillar

How to read mass spectrometry data peptide COA Durham Peptides Canada

When Canadian researchers evaluate research peptide quality, the conversation typically focuses on HPLC purity — the ≥99% benchmark that defines research-grade quality. But HPLC purity is only half of the quality verification story. The other half is mass spectrometry (MS) — the analytical technique that confirms a peptide's identity by measuring its actual molecular weight. A peptide can be 99% pure but be the wrong peptide entirely. HPLC tells you how clean it is. Mass spectrometry tells you what it is.

This article provides a practical guide to reading mass spectrometry data on a research peptide Certificate of Analysis. The framing throughout is practical interpretation — what specific numbers mean, how to verify they match the labeled compound, and why this verification step is as important as HPLC purity verification.

For complete COA reading coverage including HPLC and the Janoshik unique key system, see How to Read a Janoshik COA: HPLC, Mass Spec, and the Unique Key Explained. For unique key verification specifically, see How to Verify a Janoshik Test Report Unique Key.

The Two Pillars of COA Verification

A research-grade Certificate of Analysis answers two distinct questions about a peptide:

Pillar 1: How pure is it? Answered by HPLC (High-Performance Liquid Chromatography). The ≥99% HPLC purity benchmark is the research-grade standard. Lower purity means more impurities (typically related sequences, truncated peptides, or aggregation products) that can affect research interpretation.

Pillar 2: Is it actually what the label says it is? Answered by mass spectrometry (MS). The molecular weight measured should match the expected value for the labeled peptide.

Both pillars matter independently. A peptide that's 99% pure but is the wrong peptide produces meaningless research. A peptide that's the correct identity but only 70% pure produces noisy research with potential interference from impurities. Quality verification requires both checks.

What Mass Spectrometry Actually Measures

Mass spectrometry is an analytical technique that measures the molecular weight of compounds with high precision. The basic process:

1. The peptide sample is ionized (typically through electrospray ionization for peptide work)

2. The ionized molecules are accelerated through an electromagnetic field

3. The instrument measures the mass-to-charge ratio (m/z) of each molecular species

4. The data is processed to determine actual molecular weights

For peptide research, the relevant output is the measured molecular weight of the main peak — the actual mass of the peptide being analyzed. This measured value should match the theoretical molecular weight calculated from the peptide's amino acid sequence.

Theoretical vs Measured Molecular Weight

Every peptide has a theoretical molecular weight that can be calculated from its amino acid sequence:

• Each amino acid contributes a specific monoisotopic mass

• The sum of all amino acid masses, minus water lost during peptide bond formation, gives the peptide's theoretical mass

• Modifications (fatty acid conjugation, N-terminal tyrosine, trans-3-hexenoic acid, etc.) add specific mass values that are included in the theoretical calculation

The Janoshik COA shows both the theoretical molecular weight (the expected value) and the measured molecular weight (the actual MS result). For identity verification, these two values should match within typical instrument precision.

Reference Theoretical Molecular Weights for Common Peptides

For Canadian researchers verifying peptide identity, here are theoretical molecular weights for common research peptides in the Durham Peptides catalog:

Peptide	Approximate Theoretical MW
GHK-Cu (peptide alone)	~340 Da
KPV	~343 Da
Semax	~813 Da
MOTS-c	~2174 Da
BPC-157	~1419 Da
TB-500	~4960 Da
AOD-9604	~1817 Da
Tesamorelin	~5197 Da
Semaglutide	~4114 Da
Tirzepatide	~4814 Da
Retatrutide	~4724 Da

These approximate values are for reference. The COA's specific theoretical value should be consulted for precise verification — different molecular weight calculation methods (monoisotopic vs average) produce slightly different values.

Reading the MS Section of a COA

A typical Janoshik COA mass spectrometry section includes:

1. Theoretical molecular weight. The expected value for the labeled peptide.

2. Measured molecular weight. The actual MS result for the analyzed sample.

3. Match assessment. Often presented as a delta value (the difference between theoretical and measured) or as a pass/fail flag.

4. MS spectrum image. A visual chart showing the mass spectrum with peaks labeled by m/z values.

5. Multiple charge states. Peptides typically appear as multiple peaks corresponding to different charge states (M+H, M+2H, M+3H, etc.). The MS spectrum shows these as distinct peaks at predictable m/z values.

For identity verification, the key check is: does the measured molecular weight match the theoretical molecular weight within reasonable instrument precision (typically within a few daltons for peptides, much tighter for high-resolution MS)?

What "Match" Actually Means

Several patterns count as a confirmed match:

Exact match. Theoretical and measured values are identical to within instrument precision (sub-dalton agreement for high-resolution MS).

Match with adduct interpretation. The measured value matches an expected ion form — typically [M+H]+ (peptide plus one hydrogen ion) or higher charge states. The COA should annotate which charge state was observed.

Match with isotope pattern. The MS spectrum shows the expected isotope pattern around the main peak — the natural distribution of carbon-13, nitrogen-15, etc. that produces secondary peaks at predictable m/z offsets.

Patterns that don't count as match:

• Measured value differs by more than typical instrument precision from theoretical

• Wrong charge state pattern (different from expected for the peptide's theoretical mass)

• Multiple major peaks with different masses (suggesting multiple peptide species in the sample)

• Missing isotope pattern (suggesting analytical issues)

What Mass Spec Errors Look Like

Several patterns suggest the peptide may not be what the label claims:

1. Wrong molecular weight entirely. The measured value doesn't match the theoretical for the labeled peptide. This could indicate the wrong peptide was synthesized, mislabeled product, or substantially modified peptide structure.

2. Modification mass missing. For modified peptides (semaglutide with fatty acid conjugation, AOD-9604 with N-terminal tyrosine, tesamorelin with trans-3-hexenoic acid), the measured mass should include the modification mass. Mass without the modification suggests the unmodified parent peptide was synthesized rather than the modified compound.

3. Truncated peptide mass. The measured value matches a shorter version of the labeled peptide. This indicates incomplete synthesis or hydrolysis during manufacturing/storage.

4. Aggregation patterns. MS data showing peptide dimers (twice the monomeric mass) or higher-order aggregates suggests aggregation during manufacturing or storage.

Why Modified Peptides Need Special Attention

Several peptides in the Durham Peptides catalog have specific structural modifications that should be reflected in MS data:

Semaglutide. Includes a specific fatty acid conjugation at a specific lysine position. The molecular weight should reflect both the peptide backbone and the fatty acid attachment. Mass spec should show approximately 4114 Da, not the unmodified backbone mass.

Tirzepatide. Different fatty acid conjugation than semaglutide. Mass spec should show approximately 4814 Da.

Retatrutide. Specific structural modifications. Mass spec should show approximately 4724 Da.

AOD-9604. N-terminal tyrosine added to the unmodified HGH Fragment 176-191. Mass spec should distinguish AOD-9604 from the unmodified fragment by the tyrosine mass (~163 Da heavier).

Tesamorelin. Trans-3-hexenoic acid N-terminal modification adds specific mass beyond the native GHRH sequence.

For each of these compounds, the MS measurement is what confirms the modification was successfully incorporated during manufacturing. Mass without the modification indicates the unmodified parent peptide rather than the labeled compound.

For coverage of how manufacturing complexity relates to these modifications, see Why Some Peptides Cost More Than Others: Manufacturing Complexity Explained.

The Practical Verification Workflow

For Canadian researchers verifying mass spec data on a peptide COA:

Step 1: Identify the theoretical molecular weight. From the COA itself or from the peptide's published structure.

Step 2: Find the measured molecular weight in the MS section. Look for the main peak's m/z value, identifying which charge state it represents.

Step 3: Compare measured vs theoretical. They should match within instrument precision. For most research peptide MS work, sub-dalton agreement is achievable; agreement within a few daltons is typical.

Step 4: Verify expected modification mass for modified peptides. Particularly important for the metabolic peptides, AOD-9604, tesamorelin, and any other modified compounds.

Step 5: Look for clean spectrum patterns. A single dominant peak at the expected m/z, expected isotope pattern, no major secondary peaks suggesting different peptide species.

Step 6: If anything looks unusual, ask the supplier. Legitimate suppliers can explain MS data interpretation. Suppliers that can't or won't are flagging quality concerns.

The Combined HPLC + MS Picture

The full quality verification picture integrates both pillars:

High HPLC purity + MS identity match. The peptide is research-grade quality. This is what every batch should show.

High HPLC purity + MS identity mismatch. The peptide is clean but the wrong peptide. The HPLC purity is meaningless because the compound itself is incorrect.

Lower HPLC purity + MS identity match. The peptide is the right compound but contains impurities. Research interpretation becomes harder due to the impurity load.

Lower HPLC purity + MS identity mismatch. Both quality dimensions are compromised. The compound is wrong and the sample isn't clean.

For research-grade quality, both pillars need to pass independently. The HPLC purity check answers cleanliness. The MS identity check answers correctness.

Frequently Asked Questions

What does mass spectrometry tell me about a peptide? The actual molecular weight of the peptide. By comparing measured molecular weight to the theoretical value calculated from the peptide's structure, MS confirms the peptide's identity.

Why isn't HPLC purity enough? HPLC measures cleanliness — how much of the sample is the main compound vs impurities. It doesn't verify what the main compound actually is. A 99% pure peptide could be 99% the wrong peptide. MS adds the identity verification HPLC can't provide.

How precise should the MS match be? For typical research peptide MS, agreement within a few daltons is common. High-resolution MS can achieve sub-dalton precision. The COA should show the measurement quality and any deviation from theoretical.

What if the measured MW differs slightly from theoretical? Small deviations within instrument precision are typical. Larger deviations (more than a few daltons for typical MS) suggest the peptide may not be the labeled compound.

Can MS verify peptide modifications like fatty acid conjugation? Yes — modifications add specific mass values that should be reflected in the measured MW. For modified peptides (semaglutide, tirzepatide, retatrutide, AOD-9604, tesamorelin), MS verification of the modification mass is critical.

What if a COA doesn't include MS data? A research-grade COA should include both HPLC purity and MS identity confirmation. Missing MS data leaves identity verification incomplete. See How to Verify Peptide Quality.

How does Janoshik handle MS testing? Janoshik Analytical includes MS data as a standard part of their COA. The MS spectrum image, theoretical vs measured molecular weight comparison, and identity assessment are typical components of a Janoshik COA.

Why are charge states relevant? Peptide MS shows multiple peaks corresponding to different ionization states. The charge state pattern is predictable for a given peptide mass. Anomalous charge state patterns suggest analytical issues or unexpected sample composition.

What's monoisotopic vs average molecular weight? Monoisotopic MW uses only the most abundant isotope of each element (typically 12C, 14N, etc.). Average MW uses the natural isotopic distribution. The two values differ slightly. The COA should specify which calculation method is used for the theoretical value.

Can MS detect peptide aggregation? Yes. Aggregated peptide samples show peaks at multiples of the monomeric mass (dimer at 2x, trimer at 3x, etc.). Significant aggregation patterns indicate quality issues.

Should I verify MS data for every batch? For each new batch, yes. Each batch is independently manufactured and tested. MS verification is part of confirming the specific batch matches the labeled peptide.

How does this relate to the Janoshik unique key? The unique key system (see How to Verify a Janoshik Test Report Unique Key) verifies the COA itself is authentic. The MS data within the verified COA provides the identity confirmation. Both verifications are part of the complete quality framework.

Final Thoughts

Mass spectrometry is the underappreciated half of peptide COA verification. While HPLC purity gets most of the attention in research peptide quality discussions, MS identity confirmation is equally critical — without it, even high-purity peptides could be entirely wrong compounds. For Canadian researchers conducting rigorous research, learning to read MS data on COAs is one of the most valuable quality verification skills.

For Canadian researchers, the practical takeaways:

1. HPLC purity and MS identity are two independent quality dimensions

2. Both should pass for research-grade quality

3. Modified peptides require MS verification of the modification mass specifically

4. Sub-dalton or single-dalton agreement is typical for legitimate MS verification

5. Larger deviations or pattern anomalies are quality flags worth investigating

For continued reading, see How to Read a Janoshik COA: HPLC, Mass Spec, and the Unique Key Explained, How to Verify a Janoshik Test Report Unique Key, How to Verify Peptide Quality, Peptide Purity: Why 99% Matters, and Peptide Supplier Red Flags.

Browse the complete Durham Peptides catalog at durhampeptides.ca/category/all-products. View all Janoshik-verified COAs at durhampeptides.ca/lab-results.

Selected References

1. Aebersold R, Mann M. Mass-Spectrometric Exploration of Proteome Structure and Function. Nature. 2016;537(7620):347-355. https://pubmed.ncbi.nlm.nih.gov/27629641/

2. Domon B, Aebersold R. Mass Spectrometry and Protein Analysis. Science. 2006;312(5771):212-217. https://pubmed.ncbi.nlm.nih.gov/16614208/

3. Karas M, Hillenkamp F. Laser Desorption Ionization of Proteins with Molecular Masses Exceeding 10,000 Daltons. Analytical Chemistry. 1988;60(20):2299-2301. https://pubmed.ncbi.nlm.nih.gov/3239801/

4. International Council for Harmonisation. ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products. Standards on peptide quality testing methodology including identity confirmation.

5. D'Hondt M, Bracke N, Taevernier L, et al. Related Impurities in Peptide Medicines. Journal of Pharmaceutical and Biomedical Analysis. 2014;101:2-30. https://pubmed.ncbi.nlm.nih.gov/24909356/

6. United States Pharmacopeia. USP General Chapter on Mass Spectrometry. Pharmacopeial standards for MS analysis of pharmaceutical compounds.

All products sold by Durham Peptides are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease. This article is informational and does not constitute medical advice.